A Bermudian microbiologist has been named the new Chief of Pathology by the Bermuda Hospitals Board.

Dr Clyde Wilson will report to the Chief of Staff, Dr Michael Weitekamp, and will be responsible for all laboratory services at the BHB, including blood and urine tests, examinations of biopsies, haematology and blood transfusion services, microbiology and autopsy services.

He replaces Dr Keith Cunningham, who has been Acting Chief of Pathology and will reportedly be leaving BHB once Dr Wilson assumes the post.

“BHB has the only laboratory on-Island with full time pathologists, haematologist and microbiologist, as well as a dedicated team of technologists, phlebotomists and administrative staff,” Dr Wilson said. “We have maintained specialised laboratory accreditation with Joint Commission International alongside the hospital-wide process with Accreditation Canada for many years.

“I am looking forward to building on these strengths as Chief and working with the team to ensure we keep pace with international developments and best practices.”

Dr Wilson has worked in the field of Microbiology for more than 20 years, with a particular interest in the role of infection in the cause of autoimmune diseases such as rheumatoid arthritis.

He studied Microbiology at Queen Elizabeth College before earning his PhD in Microbiology from Kings College, University of London. In 1987, he was awarded the Tadion-Rideal Prize for distinguished post graduate work in Molecular Sciences.

He was appointed as Research Fellow and later Senior Research Fellow in the Infection and Immunity Section, Kings College, University of London, before being named the Deputy Director of the Bovine Spongiform Encephalopathy Unit at Kings College in 1999.

Dr Wilson returned to Bermuda in 2004 to act as Consultant Microbiologist at King Edward VII Memorial Hospital, and in 2006 was appointed the Director of Undergraduate Development at the hospital.

He has also authored and co-authored more than 50 peer-reviewed scientific publications and contributed to six textbooks on the role of microorganisms as trigger factors for autoimmune diseases.

Dr Weitekamp said he was pleased to make the appointment, saying: “We are very fortunate to have a Bermudian with his skills and experience to take on this critical role.

“BHB has an impressive laboratory service with highly qualified staff, and cutting edge equipment. I know Dr Wilson will continue to ensure a safe, high quality service that constantly strives for excellence.”